Reduction in local tumor recurrence in a murine R2 resection model comparing locally administered docetaxel-releasing product, OncoPLEX, versus systemic docetaxel
Name
Email Adress
I am interested in… —Please choose an option—Learning morePartnership opportunitiesInvestor Relations and Media inquiriesCareer opportunitiesOther
Message
Your information will be processed in accordance with the Privacy Policy.
